1. K. Schrör and K. Funke, Prostaglandins and myocardial noradrenaline overflow after sympathetic nerve stimulation during ischemia and reperfusion, J. Cardiovasc. Pharmacol. 7 (Suppl. 5): S50 (1985).
2. R. Ferrati, A. Cargnoni, S. Curello, C. Ceconi and E. Pasini, Protective effects of iloprost during myocardial ischaemia and reperfusion, J. Mol. Cell. Cardiol. 20 (Suppl. V): S41 (1988).
3. W.H. van Gilst, P.W. Boonstra, J.A. Terpstra, C.R.H. Wildevuur and C.D.J. de Langen, Improved recovery of cardiac function after 24 h of hypothermic arrest in the isolated rat heart: comparison of a prostacyclin analogue (ZK 36 374) and a calcium entry blocker (diltiazem), J. Cardiovasc. Pharmacol. 7: 520 (1985).
4. F. Nomura, H. Matsuda, H. Hirose, S. Nakano, S. Maeda, M. Ohtani, M. Kaneko, K. Kadoba and Y. Kawashima, Assessment of myocardial protective effects of a new prostacyclin analogue, OP-41483, Surg. Forum 37: 265 (1986).
5. E.F. Smith III, G. Kloster, G. Stöcklin and K. Schrör, Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts, Biomed. Biochim. Acta 43: S155 (1984).